Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid

Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acidImpact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid, Published online: 17 April 2019; doi:10.1038/s41397-019-0086-0Impact of SLCO1B3 polymorphisms on clinical outcomes in lung allograft recipients receiving mycophenolic acid

https://www.nature.com/articles/s41397-019-0086-0

Source: The Pharmacogenomics Journal - April 16, 2019 Category: Drugs & Pharmacology Authors: Laneshia K. Tague Derek E. Byers Ramsey Hachem Daniel Kreisel Alexander S. Krupnick Hrishikesh S. Kulkarni Catherine Chen Howard J. Huang Andrew Gelman Source Type: research

More News: Bone Graft | Drugs & Pharmacology